JPH11322599A - 同種異系移植片の拒絶反応を予防する方法 - Google Patents

同種異系移植片の拒絶反応を予防する方法

Info

Publication number
JPH11322599A
JPH11322599A JP11066202A JP6620299A JPH11322599A JP H11322599 A JPH11322599 A JP H11322599A JP 11066202 A JP11066202 A JP 11066202A JP 6620299 A JP6620299 A JP 6620299A JP H11322599 A JPH11322599 A JP H11322599A
Authority
JP
Japan
Prior art keywords
alkyl
carboxy
fluorophenyl
hydroxy
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11066202A
Other languages
English (en)
Japanese (ja)
Inventor
Henry James Showell
ヘンリー・ジェームズ・ショーウェル
Elora Jeanne Weringer
エローラ・ジーン・ウェリンガー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of JPH11322599A publication Critical patent/JPH11322599A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
JP11066202A 1998-03-12 1999-03-12 同種異系移植片の拒絶反応を予防する方法 Pending JPH11322599A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7769998P 1998-03-12 1998-03-12
US60/077699 1998-03-12

Publications (1)

Publication Number Publication Date
JPH11322599A true JPH11322599A (ja) 1999-11-24

Family

ID=22139565

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11066202A Pending JPH11322599A (ja) 1998-03-12 1999-03-12 同種異系移植片の拒絶反応を予防する方法

Country Status (8)

Country Link
EP (1) EP0943339A3 (hu)
JP (1) JPH11322599A (hu)
KR (1) KR19990077751A (hu)
AU (1) AU2038899A (hu)
CA (1) CA2265209A1 (hu)
HU (1) HUP9900601A2 (hu)
IL (1) IL128731A0 (hu)
ZA (1) ZA991978B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0963755A3 (en) * 1998-04-16 2001-03-14 Pfizer Products Inc. Use of benzopyranes for preventing allograft rejection
EP3932914A1 (en) 2015-03-13 2022-01-05 Valo Health, Inc. Alpha-cinnamide compounds and compositions as hdac8 inhibitors
AR105911A1 (es) 2015-09-03 2017-11-22 Forma Therapeutics Inc Inhibidores de hdac8 bicíclicos fusionados [6,6]
WO2017095724A1 (en) * 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Aryl sulfonamides as blt1 antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995025508A1 (en) * 1994-03-18 1995-09-28 Smithkline Beecham Corporation Treating cyclosporine-induced nephrotoxicity
WO1996011920A1 (en) * 1994-10-13 1996-04-25 Pfizer Inc. Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4 (ltb4) antagonists

Also Published As

Publication number Publication date
AU2038899A (en) 1999-09-23
HU9900601D0 (en) 1999-05-28
CA2265209A1 (en) 1999-09-12
ZA991978B (en) 2000-10-11
EP0943339A3 (en) 2001-11-07
KR19990077751A (ko) 1999-10-25
EP0943339A2 (en) 1999-09-22
HUP9900601A2 (hu) 2001-04-28
IL128731A0 (en) 2000-01-31

Similar Documents

Publication Publication Date Title
EP0017195B1 (en) Derivatives of 2,5-disubstituted-cyclohexane-1,3-diones, process for preparation thereof and pharmaceutical composition containing them
EA011895B1 (ru) Способ лечения атеросклероза, дислипидемий и связанных с ними состояний и фармацевтические композиции
CA2100944A1 (fr) 3-(hydroxybenzylidenyl)-indoline-2-ones, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
EP2771334A1 (fr) Composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines
EP0682947B1 (en) Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia
CN114456163B (zh) 四氢吡啶并嘧啶二酮类衍生物、其制备方法及其在医药上的应用
WO2022081573A1 (en) Transient receptor potential canonical 3 inhibitors and methods of use thereof
JPH11322599A (ja) 同種異系移植片の拒絶反応を予防する方法
HU202106B (en) Process for producing pharmaceutical compositions containing pyrazolin derivatives
BE1003632A3 (fr) Nouveaux derives de l'adenosine, leur preparation et leur utilisation comme medicaments.
JPH05262722A (ja) 置換ｎ−ビフエニリルラクタム類
CA2902276A1 (fr) Heterocycles phosphores analogues de sucres a activite antimetastatique
JPH11335283A (ja) 哺乳動物における同種異系移植組織の拒絶反応を抑制する方法
EP0238883A1 (en) Oxabicycloheptane derivatives, pharmaceutical composition and use
JP2798005B2 (ja) 平滑筋細胞増殖に起因する疾患の治療・予防剤
JP2838282B2 (ja) 血管攣縮治療剤
WO2002022074A2 (fr) Utilisation de 2- et 4-quinolones pour inhiber la neo-proliferation intimale
US5948813A (en) Method of preventing allograft rejection
FR2710644A1 (fr) Dérivés d'indane cétoniques et de leurs analogues hétérocycliques et leur utilisation thérapeutique.
KR20050039700A (ko) 이식거부 치료용 화합물 및 치료 방법
MXPA04006937A (es) Intermedios para la preparacion de inhibidores de la glucogeno fosforilasa.
FR2605006A1 (fr) Derives du 5-fluorouracile, procede pour leur preparation, composition anticancereuse les contenant et leur utilisation pour la preparation d'une composition destinee au traitement d'un cancer
JPH0565487B2 (hu)
KR920005275B1 (ko) 1,3-디티올-2-일리덴 유도체의 제조방법
JPH07138226A (ja) 新規な血行促進のために使用する医薬